5-FU chemotherapy also activates the p53-Fas pathway, leading to the suppression of myeloid-derived suppressor cells (MDSC) accumulation and increased cytotoxic T lymphocyte (CTL) tumor infiltration eventually enhancing antitumor immunity against CRC [15]. Here, TP53 is linked to neoplasm.